LENSAR (LNSR) Projected to Post Quarterly Earnings on Thursday

LENSAR (NASDAQ:LNSR - Get Free Report) will likely be issuing its Q1 2025 quarterly earnings data before the market opens on Thursday, May 8th. Analysts expect LENSAR to post earnings of ($0.16) per share and revenue of $13.40 million for the quarter. LENSAR has set its FY 2025 guidance at EPS and its Q1 2025 guidance at EPS.

LENSAR (NASDAQ:LNSR - Get Free Report) last issued its earnings results on Thursday, February 27th. The company reported ($1.61) EPS for the quarter, missing the consensus estimate of ($0.21) by ($1.40). The firm had revenue of $16.73 million during the quarter, compared to analysts' expectations of $14.95 million. LENSAR had a negative return on equity of 49.02% and a negative net margin of 34.03%.

LENSAR Price Performance

LNSR traded down $0.04 during trading on Tuesday, hitting $13.87. 95,683 shares of the stock traded hands, compared to its average volume of 73,508. The firm has a market capitalization of $163.50 million, a P/E ratio of -9.50 and a beta of 0.56. LENSAR has a 12-month low of $3.17 and a 12-month high of $17.31. The firm has a 50-day moving average of $14.13 and a 200 day moving average of $10.30.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on LNSR. Lake Street Capital reissued a "hold" rating and issued a $15.00 target price (down from $16.00) on shares of LENSAR in a research note on Monday, March 24th. BTIG Research lowered LENSAR from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 24th.

LENSAR Company Profile

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.